How does ivermectin work

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Ivermectin works by binding to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, causing paralysis and death of parasites. It was discovered in 1975 by Satoshi Ōmura and William C. Campbell, who won the 2015 Nobel Prize in Physiology or Medicine for this discovery. The drug is highly effective against various parasitic worms and ectoparasites, with single doses often achieving cure rates above 90% for conditions like onchocerciasis. Ivermectin has been used in over 3.7 billion treatments globally since 1987, primarily through mass drug administration programs.

Key Facts

Discovered in 1975 by Satoshi Ōmura and William C. Campbell
Won the 2015 Nobel Prize in Physiology or Medicine
Binds to glutamate-gated chloride channels in invertebrates
Used in over 3.7 billion treatments globally since 1987
Single doses achieve >90% cure rates for many parasitic infections

Overview

Ivermectin is a broad-spectrum antiparasitic medication derived from avermectins, compounds produced by the soil bacterium Streptomyces avermitilis. Discovered in 1975 through collaboration between Japanese microbiologist Satoshi Ōmura and Irish parasitologist William C. Campbell, ivermectin revolutionized parasitic disease treatment. The discovery earned them the 2015 Nobel Prize in Physiology or Medicine. Initially developed for veterinary use in 1981, human applications began in 1987 after clinical trials demonstrated safety and efficacy. Merck & Co. developed the drug under the brand name Mectizan® and established a landmark donation program in 1987 that has provided over 3.7 billion treatments to date. Ivermectin's impact has been particularly significant in tropical regions where parasitic diseases are endemic, with the World Health Organization including it on their List of Essential Medicines.

How It Works

Ivermectin exerts its antiparasitic effects through selective binding to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells. These channels, which are absent in mammals, regulate chloride ion flow across cell membranes. When ivermectin binds, it causes hyperpolarization of the cell by increasing chloride ion influx, leading to paralysis of the parasite's pharyngeal and body wall muscles. This mechanism is particularly effective against nematodes (roundworms) and arthropods. The drug also enhances the release of gamma-aminobutyric acid (GABA) at nerve synapses in some parasites, further contributing to paralysis. Ivermectin has limited effect on adult filarial worms but is highly effective against their microfilariae, reducing transmission. The drug's selectivity for invertebrate channels explains its high therapeutic index and safety in mammals at standard doses.

Why It Matters

Ivermectin's significance extends beyond individual treatment to public health transformation. It has been instrumental in controlling onchocerciasis (river blindness), reducing prevalence from over 40% to near elimination in many West African communities. The Mectizan Donation Program, established in 1987, represents one of the longest-running drug donation initiatives, preventing approximately 1.5 million cases of blindness. Ivermectin also treats lymphatic filariasis, strongyloidiasis, and scabies, affecting hundreds of millions globally. Beyond human medicine, it revolutionized livestock health, with annual economic benefits estimated at $3 billion. However, its misuse during the COVID-19 pandemic highlighted the importance of evidence-based medicine, as numerous studies found it ineffective against SARS-CoV-2 at standard doses.